Clinical Trial Update: Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates show results for nivolumab plus standard-of-care chemotherapy in patients with Peripheral T-cell lymphoma, with the study status marked …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Peripheral T Cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-29